Emerald Advisers’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-224,625
| Closed | -$8.67M | – | 243 |
|
|
2022
Q4 | $8.67M | Sell |
224,625
-269,671
| -55% | -$10.4M | 0.42% | 93 |
|
|
2022
Q3 | $26.3M | Buy |
494,296
+155,076
| +46% | +$8.25M | 1.36% | 17 |
|
|
2022
Q2 | $19.8M | Buy |
339,220
+34,172
| +11% | +$1.99M | 1.02% | 32 |
|
|
2022
Q1 | $23.3M | Buy |
+305,048
| New | +$23.3M | 0.89% | 42 |
|